Development of New Prenatal Diagnostic Tests From Maternal Blood
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00314691
(Leaving of the person responsible for the data collection)
After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Mother and father-to-be both older than 18 years old
Mother and father-to-be affiliated to social security
Mother and father-to-be have good understanding of the protocol
Pregnancy of the mother-to-be attested
Mother and father-to-be are younger than 18 years old
Mother and/or father-to be refusing to participate